Cardiff Oncology Inc. buy melinda
Start price
22.06.17
/
50%
€76.61
Target price
19.12.17
€108.00
Performance (%)
-82.61%
End price
19.12.17
€13.32
Summary
This prediction ended on 19.12.17 with a price of €13.32. Massive losses of -82.61% were the result for the BUY prediction by melinda. melinda has a follow-up prediction for Cardiff Oncology Inc. where he still thinks Cardiff Oncology Inc. is a Buy. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | -40.081% | -40.081% | -62.010% | -5.604% |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% | 57.846% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% | 93.736% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% | 51.788% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% | 61.648% |
Comments by melinda for this prediction
In the thread Trovagene diskutieren
* TrovaGene gibt Vereinbarung mit einem globalen biopharmazeutischen Unternehmen , die Tests und Dienstleistungen zu verwenden trova® ctDNS in der klinischen Krebsstudien
(Vom Mitglied beendet)
Current prediction by melinda for Cardiff Oncology Inc.
Stopped prediction by melinda for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.61
18.01.23
18.01.23
€2.00
18.01.24
18.01.24
-16.30%
19.01.24
19.01.24
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.84
05.04.19
05.04.19
€7.00
04.11.21
04.11.21
29.61%
05.11.21
05.11.21
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€76.61
22.06.17
22.06.17
€108.00
19.12.17
19.12.17
-82.61%
19.12.17
19.12.17
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€271.44
05.05.16
05.05.16
€324.00
19.05.16
19.05.16
31.03%
19.05.16
19.05.16